Structural and Functional highlights of Vacuolar Soluble Protein 1 from pathogen T. brucei. brucei

Archive ouverte

Jamwal, Abhishek | Round, Adam | Bannwarth, Ludovic | Vénien-Bryan, Catherine | Belrhali, Hassan | Yogavel, Manickam | Sharma, Amit

Edité par CCSD ; American Society for Biochemistry and Molecular Biology -

International audience. Trypanosoma brucei (T. brucei) is responsible for the fatal human disease called African trypanosomiasis or sleeping sickness. The causative parasite Trypanosoma encodes soluble versions of inorganic pyrophosphatases (PPase), also called vacuolar soluble proteins (VSPs), which are localized to its acidocalcisomes. Latter are acidic membrane enclosed organelles rich in polyphosphate chains and divalent cations whose significance in these parasites remains unclear. We here report the crystal structure of T. brucei brucei acidocalcisomal PPases in a ternary complex with Mg 2+ and imidodiphosphate. The crystal structure reveals a novel structural architecture distinct from known class I PPases in its tetrameric oligomeric state in which a fused EF-hand domain arranges around the catalytic PPase domain. This unprecedented assembly evident from TbbVSP1 crystal structure is further confirmed by small angle X-ray scattering (SAXS) and electron microscopy data. Solution scattering data suggests structural flexibility in EF-hand domains indicative of conformational plasticity within TbbVSP1.

Suggestions

Du même auteur

A Toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation

Archive ouverte | Braun, Laurence | CCSD

International audience

Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis

Archive ouverte | Baragaña, Beatriz | CCSD

International audience. Malaria and cryptosporidiosis, caused by apicomplexan parasites, remain major drivers of global child mortality. New drugs for the treatment of malaria and cryptosporidiosis, in particular, a...

Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis

Archive ouverte | Yogavel, Manickam | CCSD

International audience. The prolyl-tRNA synthetase (PRS) is a validated drug target for febrifugine and its synthetic analog halofuginone (HFG) against multiple apicomplexan parasites including Plasmodium falciparum...

Chargement des enrichissements...